The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN.
 
Eve Maubec
Consulting or Advisory Role - MSD
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Marouane Boubaya
No Relationships to Disclose
 
Peter Petrow
Travel, Accommodations, Expenses - Amgen; Bayer Health; GE Healthcare; Guerbet
 
Nicole Basset-Seguin
No Relationships to Disclose
 
Jean Jacques Grob
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Brigitte Dréno
No Relationships to Disclose
 
Marie Beylot-Barry
Research Funding - Roche (Inst)
 
Isabelle Scheer-Senyarich
No Relationships to Disclose
 
Sabine Helfen
No Relationships to Disclose
 
Marie Thérèse Leccia
No Relationships to Disclose
 
Andreea Raluca Stefan
No Relationships to Disclose
 
Philippe Saiag
Honoraria - Array BioPharma; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche
Research Funding - Array BioPharma; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Julie De Quatrebarbes
Travel, Accommodations, Expenses - Abbvie; Janssen; MSD; Novartis
 
Nicolas Meyer
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
 
Lydia Deschamps
No Relationships to Disclose
 
Céline Alloux
No Relationships to Disclose
 
Isabelle Lopez
No Relationships to Disclose
 
Soufian Cherbal
No Relationships to Disclose
 
Annick Tibi
No Relationships to Disclose
 
Vincent Lévy
No Relationships to Disclose